Century Aluminum (NASDAQ:CENX): JP Morgan moves the stock to Underweight from Neutral. GlaxoSmithKline (NYSE:GSK): Pharmaceutical giant GlaxoSmithKline sees its stock downgraded to Hold from Buy at Deutsche …
This is a bit of a knee-jerk response. Arguably, at these sort of ratings the stock is already discounting a worst-case scenario.'' GSK currently trades at less than 13 times the consensus forecast for 2003 earnings -- a discount of around …
CNN14y
So far GlaxoSmithKline plc (ADR) (NYSE:GSK)’s stock price appears to be unaffected by the news, and there is not much concern that the investigation will seriously harm the company’s profits. Even if this is the beginning of a difficult …
they can easily earn 20 percent per annum on the stock,” she adds. On the valuation front, the GSK stock—at the buyback price—would trade at around 34 times the current year (2014) estimated earnings, Angel Broking analysts …
GSK stock rose after news of the settlement, climbing 1.6% to a share price of $46.30 in late afternoon trading on the New York Stock Exchange.
GSK venture files lawsuit Zurich Insurance beats 2017 profit estimates, raises dividend Finland's Solidium sells Telia stake for 5.1 bln SEK Thomas Cook expands airline business by 10 pct for this summer TDC rejects takeover offer from …
Apple lost 1.67% of its value on Friday after a surprising drop in the early afternoon which plunged the stock down over 2% at one point. The stock dropped sharply at about 1:30 PM ET before making a slight comeback. Apparently, a German …
Nomura maintains a reduce rating on GSK Pharma and has also slashed its 12-month target ... However, the market expects strong revival in EBITDA margins and the stock is factoring in possible delisting if parent Glaxo Plc buys back …